Drug profile · INN
amlodipine + valsartan + hydrochlorothiazide
AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/160/25
amlodipine + valsartan + hydrochlorothiazide (AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/160/25) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Drug details — amlodipine + valsartan + hydrochlorothiazide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
amlodipine + valsartan + hydrochlorothiazide (AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/160/25) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is amlodipine + valsartan + hydrochlorothiazide?
amlodipine + valsartan + hydrochlorothiazide (AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/160/25) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
What is the brand name for amlodipine + valsartan + hydrochlorothiazide?
AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/160/25 is a marketed brand name for amlodipine + valsartan + hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.